Cargando…
Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease: Associations with laboratory findings, comorbidities, and medications
OBJECTIVES: To show the levels of vascular endothelial growth factor (VEGF), soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in patients with end-stage renal disease (ESRD) and to show the associations with clinical findings such as demographic features, laboratory findings, comorbi...
Autores principales: | Erturk, Ismail, Yesildal, Fatih, Acar, Ramazan, Ozgurtas, Taner, Saglam, Kenan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058753/ https://www.ncbi.nlm.nih.gov/pubmed/29915853 http://dx.doi.org/10.15537/smj.2018.6.22024 |
Ejemplares similares
-
Evaluation of the effects of different treatment modalities on angiogenesis in heart failure patients with reduced/mid-range ejection fraction via VEGF and sVEGFR-1
por: Erturk, Ismail, et al.
Publicado: (2018) -
Correlation of vascular endothelial growth factor and vascular endothelial growth factor receptor-1 levels in serum and thyroid nodules with histopathological and radiological variables
por: Haytaoglu, Gurkan, et al.
Publicado: (2019) -
Vascular endothelial growth factors and vascular permeability
por: Bates, David O.
Publicado: (2010) -
Targeting Vascular endothelial growth factor A with soluble vascular
endothelial growth factor receptor 1 ameliorates nerve injury-induced
neuropathic pain
por: Peng, Zhe, et al.
Publicado: (2022) -
Neuropilin‐1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1
por: Colotti, Gianni, et al.
Publicado: (2021)